Immuneering Corporation (IMRX)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Total Revenue | 1,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -13.99M | -14.68M | -13.51M | -13.93M | -16.3M | -15.33M | -14.91M | -15.27M |
| Pre Tax Income | -13.25M | -13.6M | -12.19M | -12.6M | -15.08M | -14.31M | -14.08M | -14.6M |
| Net Income | -13.25M | -13.6M | -12.19M | -12.6M | -15.08M | -14.31M | -14.08M | -14.6M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -13.77M | -14.44M | -13.36M | -13.45M | -15.84M | -15.11M | -14.91M | -15.14M |
| EBITDA | -13.9M | -14.6M | -13.42M | -13.84M | -16.21M | -15.23M | -14.82M | -15.18M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.92M | 2.31M | 2.08M | 317k | 0 |
| Operating Income | -6.29M | -17.08M | -33.89M | -51.75M | -58.41M |
| Pre Tax Income | -7.71M | -17.04M | -33.84M | -50.51M | -53.47M |
| Net Income | -7.71M | -17.04M | -33.54M | -50.51M | -53.47M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.65 | -1.064 | -0.548 | -0.823 | -0.797 |
| EBIT | -7.42M | -17.08M | -34.01M | -51.53M | -57.08M |
| EBITDA | -6.27M | -17.06M | -33.84M | -51.47M | -58.06M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
